Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells

Diabetes

Volumn 49, Issue 5, 2000, Pages 863-871

  Goldberg, Howard J ^a,b,c,d   Scholey, James ^b,d   Fantus, I George ^a,b,c,d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DNA; GLUCOSAMINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CONTROLLED STUDY; DIABETES MELLITUS; DNA BINDING; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GLOMERULUS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPORTER GENE;

EID: 0034083716     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.5.863     Document Type: Article

References (87)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Steffes MW, Bilous RW, Sutherland DER, Mauer SM: Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 41:679-684, 1992
3. Kriesberg JL, Ayo SH: The glomerular mesangium in diabetes mellitus. Kidney Int 43:109-113, 1993
4. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H: ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520-1527, 1992
5. Suzuki D, Miyazaki M, Jinde K, Koji T, Yagame M, Endoh M, Nomoto Y, Sakai H: In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy. Kidney Int 52:111-119, 1997
6. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, Border WA: Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 49:461-469, 1996
7. Koya D, Jirousek MR, Lin Y-W, Ishii H, Kuboki K, King GL: Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
8. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 93:536-542, 1994
9. Oh JH, Ha H, Yu MR, Lee HB: Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis. Kidney Int 54:1872-1878, 1998
10. Ayo SH, Radnik RA, Glass WF, Garoni J, Rampt ER, Appling DR, Kriesberg JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260:F185-F191, 1991
11. Sharma K, Ziyadeh F: Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol 17:80-92, 1997
12. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
13. Baynes JW, Thorpe SR: Role of oxidative stress in diabetic complications. Diabetes 48:1-9, 1999
14. O'Bryan GT, Hostetter TH: The renal hemodynamic basis of diabetic nephropathy. Semin Nephrol 17:93-100, 1997
15. Border WA, Noble NA: Interactions of transforming growth factor-β and angiotensin II in renal fibrosis. Hypertension 31:181-188, 1998
16. McClain DA, Crook ED: Hexosamines and insulin resistance. Diabetes 45:1003-1009, 1996
17. Marshall S, Bacote V, Traxinger RR: Discovery of a metabolic pathway mediating glucose-induced densenitization of the glucose transport system. J Biol Chem 266:4706-4712, 1991
18. Crook ED, Daniels MC, Smith TM, McClain DA: Regulation of insulin-stimulated glycogen synthase activity by overexpression of glutamine: fructose-6-phosphate amidotransferase in rat-1 fibroblasts. Diabetes 42:1289-1296, 1993
19. Rossetti L, Hawkins M, Chen W, Gindi J, Barzilai N: In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J Clin Invest 96:132-140, 1995
20. Baron A, Zhu J-S, Zhu J-H, Weldon H, Maianu L, Garvey WT: Glucosamine induces insulin resistance in vivo by affecting GLUT4 translocation in skeletal muscle: implications for glucose toxicity. J Clin Invest 96:2792-2801, 1995
21. Hebert LF, Daniels MC, Zhou J, Crook ED, Turner RL, Simmons ST, Neidigh JL, Zhu J-S, Baron AD, McClain DA: Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest 98:930-936, 1996
22. Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L: A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393:684-688, 1998
23. McClain DA, Paterson AJ, Roos MD, Wei X, Kudlow JE: Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci U S A 89:8150-8154, 1992
24. Sayeski PP, Kudlow JE: Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-α gene transcription. J Biol Chem 271:15237-15243, 1996
25. Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED: High glucose-induced transforming growth factor β1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101:160-169, 1998
26. Scholey J, Ly H, Fantus IG: Glucosamine increases plasminogen activator inhibitor-1 (PAI-1) promoter activity and transforming growth factor-β (TGF-β) receptor expression in primary cultured mesangial cells (Abstract). J Am Soc Nephrol 9:485A, 1998
27. Nerlich AG, Sauer U, Kolm-Litty V, Wagner E, Koch M, Schleicher ED: Expression of glutamine: fructose-6-phosphate amidotransferase in human tissues. Diabetes 47:170-178, 1998
28. Keeton MR, Curriden SA, van Zonneveld A-J, Loskutoff DJ: Identification of regulatory sequences in the type I plasminogen activator inhibitor gene responsive to transforming growth factor β. J Biol Chem 266:23048-23052, 1991
29. Arts J, Grimbergen J, Bosma PJ, Rahmsdorf HJ, Koostra T: Role of c-jun and proximal phorbol 12-myristate-13-acetate-(PMA)-responsive elements in the regulation of the basal and PMA-stimulated plasminogen-activator inhibitor-1 gene expression in HepG2 cells. Eur J Biochem 241:393-402, 1996
30. Feener EP, Northrup JM, Aiello LP, King LP: Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 95:1353-1362, 1995
31. Descheemaeker KA, Wyns S, Nelles L, Auwerx J, Ny T, Collen D: Interaction of AP-1, AP-2, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response. J Biol Chem 267:15086-15091, 1992
32. Sawdey M, Podor TJ, Loskutoff DJ: Regulation of type I plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. J Biol Chem 264:10396-10401, 1989
33. Dlugosz JA, Munk S, Zhou X, Whiteside CI: Endothelin-1-induced mesangial cell contraction involves activation of protein kinase C-α, -δ, and -ε. Am J Physiol 275:F423-F432, 1998
34. Ingram AJ, Ly H, Thai K, Kang M, Scholey JW: Activation of mesangial cell signaling cascades in response to mechanical strain. Kidney Int 55:476-485, 1999
35. Mucsi I, Skorecki K, Goldberg HJ: Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-β1 on gene expression. J Biol Chem 271:16567-16572, 1996
36. Chen Y-Q, Su M, Walia RR, Hao Q, Covington JW, Vaughan DE: Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. J Biol Chem 273:8225-8231, 1998
37. Mukhopadhyay D, Knebelmann B, Cohen HT, Ananth S, Sukhatme VP: The von-Hippel-Lindau tumor suppressor gene product interacts with Sp1 To repress vascular endothelial growth factor promoter activity. Mol Cell Biol 17:5629-5639, 1997
38. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1498, 1983
39. Sanchez-Alcazar JA, Ruiz-Cabello J, Hernandez-Munoz I, Pobre PS, de la Torre P, Siles-Rivas E, Garcia I, Kaplan O, Munoz-Yague MT, Solis-Herruzo JA: Tumor necrosis factor-α increases ATP content in metabolically inhibited L929 cells preceding cell death. J Biol Chem 272:30167-30177, 1997
40. Chomczynski P. Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
41. Zeheb R, Gelehrter TD: Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene 73:459-468, 1988
42. Feng X-II, Filvaroff EH, Derynck R: Transforming growth factor-β (TGF-β)-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. J Biol Chem 270:24237-24245, 1995
43. Hawkins M, Angelov I, Liu R, Barzilai N, Rossetti L: The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake. J Biol Chem 272:4889-4895, 1997
44. Yki-Jarvinen H, Virkamaki A, Daniels MC, McClain D, Gottschalk WK: Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo. Metabolism 47:449-455, 1998
45. Jackson SP, Tjian R: O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell 55:125-133, 1988
46. Han I, Kudlow JE: Reduced O-glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol Cell Biol 17:2550-2558, 1997
47. Hagen G, Muller S, Beato M, Suske G: Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J 13:3843-3851, 1994
48. Hata Y, Duh E, Zhang K, Robinson GS, Aiello LP: Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence. J Biol Chem 273:19294-19303, 1998
49. Matsumoto N, Laub F, Aldabe R, Zhang W, Ramirez F, Yoshida T, Terada M: Cloning the cDNA for a new human zinc finger protein difines a group of closely related Kruppel-like transcription factors. J Biol Chem 273:28229-28237, 1998
50. Cook T, Gebelein B, Mesa K, Mladek A, Urrutia R: Molecular cloning and characterization of TIEG2 reveals a new subfamily of transforming growth factor-β-inducible Sp1-like zinc finger-encoding genes involved in the regulation of cell growth. J Biol Chem 273:25929-25936, 1998
51. Hresko RC, Heimberg H, Chi MM-Y, Mueckler M: Glucosamine-induced insulin resistance in 3T3-L1 adipocytes is caused by depletion of intracellular ATP. J Biol Chem 273:20658-20668, 1998
52. Krug K, Zweibaum A: Glucosamine-induced changes in nucleotide metabolism and growth of colon-carcinoma cells in culture. Biochem J 217:701-708, 1984
53. 11P nuclear magnetic resonance results. Cancer Res 52:3782-3786, 1992
54. 2+ and cPKC. Am J Physiol 275:C1487-C1497, 1998
55. Heilig CW, Liu Y, England RL, Freytag SO, Gilbert JD, Heilig KO, Zhu M, Concepcion LA, Brosius FC: D-Glucose stimulates mesangial cell GLUT1 expression and basal and IGF-1-sensitive glucose uptake in rat mesangial cells. Diabetes 46:1030-1039, 1997
56. Robinson KA, Weinstein ML, Lindenmeyer GE, Buse MG: Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 44:1438-1446, 1995
57. Alroy I, Soussan L, Seger K, Yarden Y: Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor. Mol Cell Biol 19:1961-1972, 1999
58. Saffer JD, Jackson SP, Annarella MB: Developmental expression of Sp1 in the mouse. Mol Cell Biol 11:2189-2199, 1991
59. Suzuki M, Oda E, Nakajima T, Sekiya S, Oda K: Induction of Sp1 in differentiating human embryonal carcinoma cells triggers transcription of the fibronectin gene. Mol Cell Biol 18:3010-3020, 1998
60. Udvadia AJ, Templeton DJ, Horowitz JM: Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires ainino acids necessary for growth suppression. Proc Natl Acad Sci U S A 92:3953-3957, 1995
61. Daniel S, Zhang S, DePaoli-Roach AA, Kim K-H: Dephosphorylation of Sp1 by protein phosphatase 1 is involved in the glucose-mediated activation of the acetyl-CoA carboxylase gene. J Biol Chem 271:14692-14697, 1996
62. Rohiff C, Ahmad S, Borellini F, Lei J, Glazer RI: Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. J Biol Chem 272:21137-21141, 1997
63. Pal S, Claffey KP, Cohen HT, Mukhopadhyay D: Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C ζ. J Biol Chem 273:26277-26280, 1998
64. D'Angelo DD, Oliver BG, Davis MG, McCluskey TS, Dorn GW: Novel role for Sp1 in phorbol ester enhancement of human platelet thromboxane receptor gene expression. J Biol Chem 271:19696-19704, 1996
65. Merchant JL, Du M, Todisco A: Sp1 phosphorylation by Erk 2 stimulates DNA binding. Biochem Biophys Res Commun 254:454-461, 1999
66. Hart GW: Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem 66:315-335, 1997
67. Elbein AD: Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annu Rev Biochem 56:497-534, 1987
68. Koch HU, Schwarz RT, Scholtissek C: Glucosamine itself mediates reversible inhibition of protein glycosylation. Eur J Biochem 94:515-522, 1979
69. Discher DJ, Bishopric NH, Wu X, Peterson CA, Webster KA: Hypoxia regulates β-enolase and pyruvate kinase-M promoters by modulating Sp1/Sp3 binding to a conserved GC element. J Biol Chem 273:26087-26093, 1998
70. II250 to regulate Sp1-mediated transcription. Oncogene 18:239-247, 1999
71. Pascal E, Tjian R: Different activation domains of Sp1 govern formation of multimers and mediate tnascriptional synergism. Genes Dev 5:1646-1656, 1991
72. Ryu S, Zhou S, Ladurner AG, Tjian R: The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature 397:446-450, 1999
73. Roos MD, Su K, Baker JR, Kudlow JE: O-glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol Cell Biol 17:6472-6480, 1997
74. Moustakas A, Kardassis D: Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad U S A 95:6733-6738, 1998
75. Virkamaki A, Yki-Jarvinen H: Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart. Diabetes 48:1101-1107, 1999
76. Kim S-J, Onwuta US, Lee YIK, Li R, Botchan MR. Robbins PD: The retinoblastoma gene product regulates Sp1-mediated transcription. Mol Cell Biol 12: 2455-2463, 1992
77. WAFI cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J Biol Chem 273:10696-10701, 1998
78. Noti JD, Reinemann BC, Petrus MN:Sp1 binds two sites in the CD11c promoter in vivo specifically in myeloid cells and cooperates with AP1 to activate transcription. Mol Cell Biol 16:2940-2950, 1996
79. Filippis A, Clark S, Proietto J: Increased flux through the hexosamine biosynthesis pathway inhibits glucose transport acutely by activation of protein kinase C. Biochem J 324:981-985, 1997
80. Kolm-Litty V, Tippmer S, Haring H-U, Schleicher E: Glucosamine induces translocation of protein kinase C isoezymes in mesangial cells. Exp Clin Endocrinol Diabetes 106:377-383, 1998
81. Shankland SJ, Scholey JW, Ly H, Thai K: Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int 46:430-442, 1994
82. Fisher EJ, McLennan SV, Yue DK, Turtle JR: High glucose reduces generation of plasmin activity by mesangial cells. Microvasc Res 53: 173-178, 1997
83. Nordt TK, Klassen KJ, Schneider DJ, Sobel BE: Augmentation of synthesis of plasminogen activator inhibitor-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis. Arterioscler Thromb 13: 1822-1828, 1993
84. Maiello M, Boeri D, Podesta F, Cagliero E, Vichi M, Odeti P, Adezati L, Lorenz M: Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes 41:1009-1015, 1992
85. Oikawa T, Freeman M, Lo W, Vaughan DE, Fogo A: Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int 51:164-172, 1997
86. Eltzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, Simon RH: Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97:232-237, 1996
87. Tomooka S, Border WA, Marshall BC, Noble NA: Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 42:1462-1469, 1992